Cas:361342-50-9 3,3′-Di(9-anthryl)-1,1′-binaphthalene-2,2′-diol manufacturer & supplier

Chemical Name:3,3′-Di(9-anthryl)-1,1′-binaphthalene-2,2′-diol

CAS.NO:361342-50-9

Synonyms:[1,1′-Binaphthalene]-2,2′-diol, 3,3′-di-9-anthracenyl-;3,3′-Di(9-anthryl)-1,1′-binaphthalene-2,2′-diol;(S)-3,3′-Di(anthracen-9-yl)-1,1′-binaphthyl-2,2′-diol

Molecular Formula:C₄₈H₃₀O₂

Molecular Weight:638.751

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.3±0.1 g/cm3

Index of Refraction:1.814

PSA:40.46000

Exact Mass:638.224609

LogP:12.77

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like [1,1′-Binaphthalene]-2,2′-diol, 3,3′-di-9-anthracenyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-3,3′-Di(anthracen-9-yl)-1,1′-binaphthyl-2,2′-diol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,3′-Di(9-anthryl)-1,1′-binaphthalene-2,2′-diol Use and application,[1,1′-Binaphthalene]-2,2′-diol, 3,3′-di-9-anthracenyl- technical grade,usp/ep/jp grade.

Related News: Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. 3,3′-Di(9-anthryl)-1,1′-binaphthalene-2,2′-diol manufacturer In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum. 3,3′-Di(9-anthryl)-1,1′-binaphthalene-2,2′-diol supplier In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum. 3,3′-Di(9-anthryl)-1,1′-binaphthalene-2,2′-diol vendor Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. 3,3′-Di(9-anthryl)-1,1′-binaphthalene-2,2′-diol factory A U.S. Senator, New Jersey Democrat Bob Menendez, called allegations of manufacturing irregularities and records tampering at the Branchburg plant troubling. Menendez has sponsored a bill calling for a non-partisan, independent COVID-19 Commission to examine the U.S. pandemic response, including government contracts with companies.